Patients with hypergastrinaemic duodenal ulcer disease were studied to determine whether chronic moderate hypergastrinaemia produces hyperplasia of gastric enterochromaffin-like celis in man. Eight patients had peak postprandial plasma gastrin concentrations >200 pmol/l, which is the 92nd percentile for patients with duodenal ulcer disease in this laboratory. The control group was eight patients with duodenal ulcers whose peak postprandial gastrin concentrations were <200 pmol/l. Basal 
Human gastric mucosa contains enterochromaffin-like cells which are the major progenitors of carcinoid tumours at this site. Some patients with pernicious anaemia develop gastric enterochromaffin-like cell hyperplasia, and a few develop gastric carcinoid tumours. The trophic effect of gastrin which circulates in high concentrations in the absence of gastric acid may be responsible for these changes. Experimental animals also develop enterochromaffin-like hyperplasia and 
Methods
The study was approved by the hospital ethics committee and all subjects gave informed consent.
In a preliminary study of 50 patients with duodenal ulcer disease, the mean peak postprandial gastrin concentration was 106 pmol/l with a range of 29-584 pmol/l. Four patients had peak postprandial serum gastrin concentrations >200 pmol/l. These four patients, plus two with peak levels >180 pmol/l, were reinvestigated together with 10 other patients with known duodenal ulcer disease. No patient had taken any medication the two weeks before the study and none had undergone gastrointestinal surgery or vagotomy.
Patients fasted overnight before admission to a programmed investigation unit (Fig 1) . Nucleated, stained cells were counted using a light microscope with a high power field aligned so that one edge lay against the muscularis mucosae and the full depth of the mucosa was scanned. As no specific stain exists for the enterochromaffin-like cells, a subtracting method was used. Enterochromaffin cell numbers (serotonin-immunoreactive) were subtracted from the number of Grimelius-positive cells and both enterochromaffin and D (somatostatin-immunoreactive) cell numbers were subtracted from the total of chromogranin-immunoreactive cells. In all cases, the latter method of calculation gave higher enterochromaffin-like cell numbers, probably because ofthe sensitivity ofthe staining methods, and was used to obtain the final figures.
Blood samples for gastrin assay were collected into chilled tubes containing EDTA (5 mmol/l blood), plasma separated at 4°C, and stored at -20°C until assay. Gastrin was measured by radioimmunoassay based on gastrin specific antiserum 1611 donated by Dr J H Walsh, using published methods.'7 Some subjects also had a standard pentagastrin test performed on another day, using an intravenous infusion of pentagastrin, 6 rtg/kg/h, with intragastric phenol red to correct for pyloric losses. ' (peak >200 pmol/l) with the eight patients with 'low gastrin' (peak <200 pmol/l). The 'high gastrin' group contained three men and five women and had a mean age of46 years (range 39-55). The 'low gastrin' group contained four men and four women and had a mean age of 52 years (range 28-60). Plasma gastrin had been measured in 10 ofthe patients at least three years before the present study. Peak postprandial gastrin concentrations in six of the patients in the 'high gastrin' group and four of the patients in the 'low gastrin' group were 288 (99) and 84 (30) pmol/l (mean (SEM)) respectively in the previous study.
Five members of each group had pentagastrin tests. Basal acid output was 5 (2) and 3 (1) mmol/h respectively (NSD) and peak acid output was 49 (6) and 55 (8) mmol/h respectively (NSD) in the 'high' and 'low gastrin' groups.
The 24 hour gastrin profiles for the two groups are shown in Figure 2 . As expected, plasma gastrin concentrations were significantly different between the two groups at every time point during the 24 hour period. The means of gastrin concentrations throughout the day were also significantly different (Table) .
Despite the difference in serum gastrin, the number of enterochromaffin-like cells per high power field were not significantly different in the two groups. The mean enterochromaffin-like cell counts in the 'high' and 'low gastrin' groups were 53 (8) The main concern is that newer treatments of peptic ulcer disease might cause enterochromaffmlike cell hyperplasia and gastric carcinoid tumours. This is difficult to resolve because hypergastrinaemia may have to be prolonged to affect enterochromaffin-like cells. We undertook the current study having observed that the hypergastrinaemia of antral origin in patients with duodenal ulcer persists for years.'2 In the present study, plasma gastrin concentrations were consistent over a three year period. Hypergastrinaemic duodenal ulcer patients typically have basal and postprandial plasma gastrin concentrations about two or three times the mean ofthose found in duodenal ulcer patients as a whole. This may be compared with a rise in plasma gastrin concentrations by about 60% on ranitidine 150 mg bid and cimetidine 300 mg qid,8 about 30% on omeprazole 20 mg daily,9 
